Pharma major Dr Reddy’s Laboratories has launched Quetiapine fumarate tablets in the US market.
A bioequivalent generic version of Seroquel tablets, it is indicated for the treatment of schizophrenia and other depression-related disorders.
The Hyderabad-based company launched the drug in the US market on March 27, according to a release issued here on Wednesday.
The Seroquel brand had US sales of approximately $4.6 billion for the most recent 12 months ended December 2011 according to IMS Health, the release said.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.